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Abstract  
Nicotine, an alkaloid found in tobacco leaves, has been used by humans for its 
psychoactive properties for centuries. Specifically, nicotine has been consistently shown 
to improve cognitive performance (Heishman, Kleykamp, & Singleton, 2010). Similar 
effects also have been shown with exercise (Chang, Labban, Gapin, & Etnier, 2012). The 
purpose of the present study was to examine whether a 20 min bout of moderate-intensity 
exercise enhances cognitive performance (working memory) as effectively as 4 mg of 
NICORETTE® gum in a non-smoker population. Twenty-three non-smokers (M age = 
25.87; 13 female) underwent a three-week randomized counterbalanced procedure. The 
N-Back Task was used to measure working memory after administration of nicotine or 
exercise. Findings showed significant improvements in reaction time after both 
treatments. However, accuracy significantly improved only for exercise. The author 
recommends exercise over nicotine as a safe and effective strategy for non-smokers to 
enhance cognitive performance. Implications for future studies are discussed.  
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Chapter One: Literature Review 
1 Introduction 
 In the past couple years, Canadians have seen the amount of smokers aged 12 and older 
drop from 19.3% to 18.1% (Statistics Canada, 2014). This decline represented the lowest 
smoking rate reported since 2001. Smoking, however, remains a problem for 5.4 million 
Canadians and is the leading cause of preventable death (Why tobacco control is 
important, 2016). Furthermore, smoking is a risk factor for many diseases including lung 
cancer, heart disease, strokes and respiratory diseases (Surgeon General, 2014). 
Fortunately, smoking cessation can reduce the risk of these diseases and quitting has 
immediate and long-term health benefits. Within 12 hours of quitting one experiences 
improved lung function, blood circulation, and removal of carbon monoxide from the 
blood (Health Canada, 2012). Those who remain smoke-free for 15 years reduce their 
risk of coronary heart disease, and strokes to that of a non-smoker and reduce the risk of 
dying in half compared to those continuing to smoke.  The problem does not lie in 
smokers’ desire to quit as 75% said they would quit when asked ‘If you could quit 
painlessly would you quit smoking or would you continue to smoke?’ (Mullins & 
Borland, 1996). Despite this, most quitters end up relapsing in the first eight days 
(Hughes, Keely, & Naud, 2004), while only 3-5% of unassisted quitters reach the one-
year mark (CDCP, 2011).  Disturbingly, almost half of lung cancer patients continue to 
smoke post surgery (Davison & Duffy, 1982; Walker et al., 2006), forty percent continue 
after undergoing laryngectomy (Himbury & West, 1985), and amongst those suffering a 
heart attack, forty percent relapse before leaving the hospital (Bigelow, Rand, Gross, 
Burling, & Gottlieb, 1986). These numbers indicate how challenging quitting is. This 
difficulty is not surprising as smoking has been known for its highly addictive nature 
since its introduction to the western world (Ferrence, Slade, Room, & Pope, 2000). 
Nicotine is one of the main culprits making smoking so addictive. 
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1.1 Nicotine Dependence 
Nicotine acts as the principal psychoactive component in tobacco (Karan, Dani, & 
Benowitz, 2003). Cigarettes transport nicotine to the brain more efficiently than any other 
tobacco product as it delivers it to the brain within seven seconds of inhalation (Maisto, 
Galizio, & Connors, 2004). The average dose of nicotine each cigarette delivers is 1 to 2 
mg of nicotine (Karan et al., 2003). Each smoker takes around 11 puffs per cigarette 
(USDHHS, 1988) and the average Canadian smoker smokes 13.9 cigarettes per day 
(Tobacco Use in Canada: Patterns and Trends, 2015) as the body metabolizes nicotine 
fairly quickly. Nicotine blood concentration levels can drop to half within two to three 
hours after smoking (Lynch & Bonnie, 1994). 
Upon quitting, smokers experience a barrage of unpleasant signs and symptoms 
(Stolerman & Jarvis, 1995). Just after 12 hours of abstaining, smokers report cravings for 
tobacco, being irritable, cognitive impairments, restless, anxious, depressed mood, 
difficulty concentrating and increased hunger (Carruthers & Feyerabend, 1984; Bell, 
Taylor, Singleton, Henningfield, & Heishman, 1999; Gross, Javik & Rosenblatt, 1993; 
Hughes 1992; Hughes & Hatsukami 1986; Hughes, Hatsukami, Pickens, Krahn, Malin, & 
Luknic, 1984; Lyvers, Maltzman, & Miyata, 1994; West, Jarvis, Russell). These 
withdrawal effects manifest even after abstaining from nicotine chewing gum (West & 
Russell 1985; Hughes et al., 1986) further incriminating nicotine. Although it does not 
carry the same stigma, nicotine is as addictive as other drugs such as cocaine and heroin 
(USDHHS, 1988; SCOTH 1998; RCP 2000). Furthermore, nicotine meets the criteria for 
dependence  (WHO, 1992) as it leads to tolerance, withdrawal, impaired control, neglect 
of activities, time spent in substance-related activity, continued use despite problems, and 
compulsion. The neurological effect of nicotine serves as a powerful driving force of this 
disorder; however, behavioural, genetic, and cognitive performance factors contribute as 
well. These are discussed in detail below. 
1.2 Neurological factors  
Nicotine’s substantial impact is partially due to its ability to imitate the role of the natural 
neurotransmitter acetylcholine and bind to the presynaptic nicotinic acetylcholine 
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receptors (nAChRs) in the brain (Di Matteo, Pierucci, Di Giovanni, Benigno, & Esposito, 
2007). Upon binding, it releases many neurotransmitters including: glutamate (learning 
and memory enhancement), norepinephrine (arousal and appetite suppression) dopamine 
(reward-motivated behaviour), serotonin (mood and appetite modulation), and GABA 
(reduction in anxiety and tension Benowitz, 2008). Similar to other drugs and naturally 
rewarding stimuli like food, nicotine increases dopamine release in the nucleus 
accumbens (Brazell Mitchell, Joseph, & Gray, 1990; Benwell & Balfour 1992; Imperato, 
Mulas, & Di Chiara 1986; Rose & Corrigall 1997; Rowell Carr, & Garner, 1987; Salgado 
& Kaplitt, 2015). There is a substantial body of evidence indicating dopamine in the 
accumbens plays a prominent role in our reward system as it elicits euphoric feelings and 
reinforces future smoking behaviour (Benowitz, 2010; Wonnacott, Sidhpura, & Balfour, 
2005). Alternating this pathway leads to abuse and addiction by causing an increase in 
sensitivity of the drug and decreased interest in non-drug stimuli (Melis, Spiga, & Diana, 
2005). Moreover, lesions of the mesolimbic dopamine system weaken self-administration 
of nicotine (Corrigall et al., 1992). The role of nicotine in the accumbens is just one 
reason smoking is addictive. 
1.3 Behavioural factors 
The perceived cognitive benefits attained from smoking helps maintain the habit in many 
(West, 1993). Therefore, smokers might partake during stressful situations or whenever 
undergoing a lull. The intensity of one’s cravings and withdrawal symptoms can predict 
their relapse rate (Swan, Ward, & Jack, 1996). These cravings and withdrawal symptoms 
act analogous to an electric shock one receives as a form of punishment upon quitting and 
negatively reinforces the act of quitting (Eissenberg, 2004). The best way to 
alleviate/prevent this electric shock-cravings and withdrawal symptoms is to relapse and 
smoke. As the smoker learns these consequences they become conditioned to smoke, this 
type of learning is similar to operant conditioning (Skinner, 1963). As nicotine 
deprivation can negatively reinforce the habit; nicotine administration can positively 
reinforce smoking (Glautier, 2004). Six different species (rats, rhesus monkeys, squirrel 
monkeys, baboons, dogs and humans), have demonstrated that pure nicotine can serve as 
a positive reinforcer (Henningfield & Goldberg 1984; Stolerman 1987; Swedberg, 
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Henningfield, & Goldberg, 1990). Upon administration in humans, smoking is the 
unconditioned stimulus and cigarette cravings/withdrawal symptoms act as the 
unconditioned response, while neutral stimulus becomes drug-related cues (conditioned 
stimuli) and is parried with the drug and the hedonic drug effects it delivers (Pavlov, 
1927). These conditioned stimuli can be situational cues like smoking while drinking 
coffee, cigarette smell and sight, and ashtrays or lighters. They can trigger cravings and 
withdrawal post pairing (Bevins & Palmatier, 2004; Niaura, 2000). Smokers quickly 
associate the act of smoking with pleasure and are motivated to perform this act anytime 
they are stressed or exposed to drug-related cues (Benowitz 2008; Gilbert 1995; Kassel, 
Stroud & Paronis 2003).  
1.4 Genetic factors 
The Cytochrome P450 2A6 (CYP2A6) encodes for an enzyme involved in the metabolic 
inactivation from nicotine to cotinine (Nakajima et al., 1996) and is a known candidate 
gene for smoking (Tobacco and Genetics Consortium, 2010). Different types of CYP2A6 
metabolize nicotine at different speeds (Mwenifumbo & Tyndale, 2009). A slower 
metabolism is associated with lower prevalence of smoking and reduced cigarette use 
(Mwenifumbo & Tyndale, 2009; Ray, Tyndale, & Lerman, 2009). Smokers with the fast 
metabolism version of the gene smoke more and have their first cigarette earlier during 
the day. Furthermore, they report more intense withdrawal symptoms than those with 
slower nicotine metabolism (Kubota et al., 2006). Eight single nucleotide polymorphism 
around brain-derived neurotrophic factor (BDNF) are associated with smoking initiation 
(Tobacco and Genetics Consortium, 2010) and BDNF helps regulate synaptic plasticity 
and survival of cholinergic-dopaminergic neurons (Zhang, & Poo, 2001). Moreover, the 
prefrontal cortex and hippocampus have high levels of BDNF; these areas have 
implication in the cognitive enhancing effects of nicotine (Levin, McClernon, & Rezvani, 
2006). Different genetic variations at BDNF might be altering the rewarding effects of 
nicotine by modifying the dopamine reward circuits and allowing the creation of drug-
related memories that promote nicotine use after exposure. One single nucleotide 
polymorphism is associated with smoking cessations. Located 23 kb 5’ of DBH on 
chromosome 9 it accounts for 0.19% of the variance in smoking cessation (Tobacco and 
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Genetics Consortium, 2010). Three different loci have been associated with number of 
cigarettes per day; the SNP rs1051730 in CHRNA3 has the strongest association 
accounting for 0.5 of the variance. The SNP rs16969968 in CHRNA3, rs684513[G] in 
CHRNA5, and re9788682[G] and rs7163730[G] in LOC123688 also influence cigarettes 
per day independently. 
1.5 Cognitive factors 
Difficulty concentrating-due to nicotine deprivation-is a recognized symptom of nicotine 
withdrawal (Hughes, 2007) that leads to relapse and maintains smoking habits (American 
Psychiatric Association, 2000; Heishman, Taylor, & Henningfield, 1994). Furthermore, 
smoking eliminates these withdrawal-induced deficits (Heishman et al., 1994), and 
nicotine exposure increases alertness, vigor, and arousal (Gilbert, Dibb, Plath, & Hiyane, 
2000; Perkins et al., 1994; Perkins, Grobe, Weiss, Fonte, & Caggiula, 1996). Abstaining 
from smoking negatively impacts working memory, sustained attention and response 
inhibition (Ashare, Falcone, & Lerman, 2014; Snyder & Henningfield 1989), while 
cognitive impairs are detected just 4 hours of abstaining and could last more than nine 
days after the initial deprivation (Snyder & Henningfield, 1989). Hence, people that wish 
to quit face an uphill battle. Quitters deal with cravings, cognitive deficits, and 
withdrawal symptoms, which are all relapse factors, and the more intense, the faster the 
relapse (Swan et al., 1996). Expectedly, two-quarters of unaided quit attempts relapse 
within the first week (Hughes, 1992). Consequently, different smoking aids have been 
generated to aid quit attempts. 
1.6 Quitting aids/treatments 
Several quit-smoking aids are available for smokers to pick from (Lancaster, Stead, 
Silgay, & Swoden, 2000) such as: behavioural and psychological interventions (e.g. 
Cognitive-Behavioural Therapy, Exercise), Nicotine Replacement Therapy (NRT) 
(Lancaster et al., 2000), e-cigarettes (Brown, Beard, Kotz, Michie, & West, 2014) 
computer and other electronic aids (Chen et al., 2012), Exercise (Roberts et al., 2012) and 
pharmacological interventions (Antidepressants- nortriptyline, non-tricyclic 
antidepressant-Bupropion, nicotine receptor partial agonists-varenicline and cytosine). 
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The effectiveness of the different cessation strategies is shown in Table 1. 
Table 1: Percent Abstinent at Six Months for Smoking Cessation Strategies 
(USDHHS, 2008) 
Cessation strategies            % abstinent [95% CI] 
Physician advise to quit  10.2 [8.5, 12.0] 
Behavioural interventions   
    Proactive telephone counseling  13.1 [11.4, 14.8] 
    Group counseling  13.9 [11.6, 16.1] 
    Individual counseling 
    Exercise-aided counseling  
 
 
16.8 [14.7, 19.1] 
24.6 [15. 78]*b 
 
Pharmacotherapy interventions 
     
 
    Nicotine patch (6 – 14 weeks)  23.4 (21.3, 25.8) 
    Nicotine gum (6 – 14 weeks)  19.0 (16.5, 21.9) 
    Nicotine lozenge (2 mg)   24.2a 
    Nicotine inhaler  24.8 [19.1, 31.6] 
    Bupropion SR  24.2 [22.2, 26.4] 
    Varenicline (2 mg/day) 
    Vaccine  
    Exercise aided nicotine 
 33.2 [28.9, 37.8] 
15.0 [20, 67]** 
26.7***a 
   
Note. CI = Confidence Interval a95% CI not reported. bThree months for smoking 
cessation. * Marcus et al., 1999. ** Hartmann-Boyce, Cahill, Hatsukami, & Cornuz, 
2012. *** Abrantes et al., 2014; Prapavessis, Cameron, Baldi, Robinson, Borrie, Harper, 
& Grove, 2007; Prapavessis, De Jesus, Fitzgeorge, Faulkner, Maddison, & Batten, 2016 
1.7 A closer examination of nicotine and cognition 
A plethora of research has demonstrated nicotine’s ability to protect smokers from 
cognitive deficits during a quit attempt (Atzori Lemmonds, Kotler, Durcan, & Boyle 
2008; Heishman, Kleykamp, & Singleton, 2010; Heishman, et al., 1994; Wesnes, 
Warburton, & Matz, 1983; West, 1993). This research, however, does not differentiate 
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whether nicotine only reverses cognitive deficits or improves cognitive performances 
(Heishman, Snyder, & Henningfield, 1993). Furthermore, smokers abstaining overnight 
might not be nicotine free as their plasma nicotine levels are as high as 5-10 ng/ml 
(Benowitz, Jacob, Jones, & Rosenberg 1982). This occurrence could explain why some 
studies failed to demonstrate nicotine’s benefits on cognitive performances (Grundey, 
Amu, Ambrus, Batsikadze, Paulus, & Nitsche, 2015; Kleykamp, Jennings, Blank, & 
Eissenberg, 2005; Myers, Taylor, Moolchan, & Heishman, 2008). There are three 
populations of interest worth examining to clarify this issue: not deprived smokers, 
minimally deprived smokers and non-smokers. In a 2010 meta-analysis conducted by 
Heishman and colleagues, the effects of nicotine on cognitive domains were assessed. 
The purpose of that study was to examine whether nicotine can improve cognitive 
performances and included studies with adult nonsmokers, smokers who were minimally 
deprived (less than 2 h), or smokers who were not deprived. The study included nine 
performance domains and out of those nine, six domains showed significant positive 
effects after administering nicotine: fine motor, alerting attention-accuracy and reaction 
time, orienting attention reaction time, short-term episodic memory-accuracy and 
working memory reaction time. These findings show that nicotine does not merely 
relieve cravings and related withdrawal symptoms in smokers; it also enhances cognitive 
performance in nonsmokers and not deprived smokers. These findings have been 
replicated in patients with schizophrenia, Alzheimer’s, ADHD, Parkinson’s diseases and 
other age-related cognitive declines (Evans & Drobes 2009; Levin et al., 2006; Newhouse, 
Potter, & Singh, 2004). 
Nicotine may improve cognition via its ability to interact with the presynaptic nAChR 
receptors in the brain and aid the release of ACh, dopamine, serotonin, glutamate, and γ-
aminobutryic acid (Heishman et al., 2010; Samuels & Davis 1998; Wonnacott 1997). 
These neurotransmitters are associated with learning and memory (Martin & Aceto, 
1981). Specifically, the α7 and α4β2 nicotinic receptors found in the hippocampus of rats 
play a fundamental role in nicotine’s effect on cognitive functioning (Rezvani & Levin, 
2001) and these receptors in the hippocampus and basolateral amygdala mediate 
nicotine’s role in memory (Levin et al., 2006; Mansvelder et al., 2006). Nicotine also 
increases hippocampal long-term potentiation (Hamid, Dawe, Gray, & Stephenson, 1997) 
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and facilitates hippocampal synaptic activity (Gray, Rajan, Radcliffe, Yakehiro, & Dani, 
1996) causing the hippocampus to play an important role in nicotine’s effects on memory.  
Nicotine activates several other brain regions involved in attention and memory 
including: the prefrontal cortex, partietal cortex, and thalamus (Azizian, Monterosso, 
O'Neill, & London, 2009; Brody 2006; Levin et al., 2006). Like the hippocampus, these 
areas are known to contain high densities of nAChRs. Levels of ACh increases in rats 
prefrontal cortex (PFC) in tasks that require attention (Himmelheber, Sarter, & Bruno, 
2000; Passetti, Dalley, O'connell, Everitt, & Robbins, 2000). Nicotine administration 
activates the PFC in a similar manner as nAChr receptors are involved in PFC functions 
(Brody 2006; Levin et al., 2006; Azizian et al., 2009).  
Nonsmokers receiving nicotine enjoy enhanced cortical facilitation as they experience 
cortical excitability (Grundey et al., 2015). Cortical excitability and plasticity are possible 
biomarkers for cognitive functioning (Miniussi & Ruzzoli 2013). Nicotine also alters 
norepinephrine and neural activity in the locus coeruleus, which is known to be part of 
the alerting/arousal network (Fan, McCandliss, Fossella, Flombaum, & Posner, 2005; 
Posner & Rothbart 2007). Improvement in working memory performance in non-smokers 
is due to the enhancement of cortical excitability they enjoy post nicotine (Grundey, 
Freznosa, Klinker, Lang, Paulus, & Nitsche, 2013). Chronic nicotine administration leads 
to withdrawal upon cessation, which in turn leads to a down-regulation of the glutamate 
receptor function (Li, Semenova, D'Souza, Stoker, & Markou, 2014). The glutamate 
system is critically involved in working memory performances. Consequently, any down-
regulation leads to performance deterioration in nicotine-deprived smokers (Driesen et 
al., 2013). Lastly, the glutamatergic system controls intracortical facilitation. Upon 
quitting, deprived smokers experience decreased intracortical facilitation (Grundey et al., 
2013; Lang et al., 2008). Nicotine administration, however, restores compromised 
cortical facilitation returning it to baseline levels. 
1.8 Exercise and cognition 
Similar to nicotine, exercise enhances cognitive performances (Chang et al., 2012; 
Lambourne & Tomporowski, 2010; McMorris & Hale, 2012). Duration and intensity of 
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exercise play a role in determining the effects exercise will have on cognitive 
performances (Chang et al., 2012). Short exercise sessions (< 10 min) show a negligible 
effect while exercise bouts over 11 min show significant effects on cognitive 
performances. In general, it seems that 20 min of exercise is necessary to see 
enhancement. If the test is performed immediately after exercise, lighter intensity 
exercise will show these positive effects, however, if the delay is greater than 1 min 
between exercising and testing, very light exercise no longer shows any improvement 
while harder intensities (moderate or vigorous) show the most improvement. While the 
best cognitive improvements occur with moderate intensity (Kamijo, Nishihira, 
Higashiura, & Kuroiwa, 2007), the effects of exercise on cognitive performances might 
be an inverted-U as exercising until exhaustion leads to impairment on cognitive 
performance (Brown & Bray, 2014; Chang et al., 2012; Lambourne & Tomporowski, 
2010; McMorris & Hale, 2012). Moderate-intensity exercise is known to show the best 
cognitive improvements (Kamijo et al., 2007; Gondola, 1987; Heckler & Croce, 1992; 
Sibley, Etnier, & Le Masurier, 2006; Tomporowski, 2003) and is easy enough to be done 
by untrained individuals.  
Despite plenty of research being conducted on exercises and its effects on cognitive 
performances, studies examining its effects on smokers undergoing a quit attempt is 
limited. Self-reported evidence suggests poor concentration is reduced after engaging in 5 
min (Daniel, Cropley, Ussher, & West, 2004) and 10 min (Ussher, Nunziata, Cropley, & 
West, 2001) of cycling or a 15 min brisk walk (Taylor & Katomeri, 2007). Only one 
study, however, has used objective measures in this population examining exercises 
effects on cognitive performance (Van Rensburg & Taylor, 2008). Van Rensburg & 
Taylor tested the effect of a 15 min self-paced walk on an attention task (Stroop colour-
word interference task). Although participants in the exercise condition showed a 
reduction in desire to smoke, they did not see any improvement in cognitive functioning 
relative to passive controls. As no baseline measure of cognitive performance was taken 
while participants were still smoking, it cannot be deduced whether smokers performance 
declined as a function of abstinence and returned to baseline levels after exercise. 
Furthermore, participants were instructed to go on a brisk walk but were allowed to set 
the paced themselves. The lack of results could be due to the exercise intensity 
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participants chose to walk at. This pace could be insufficiently intense to impact 
cognitive functioning. 
Increase in catecholamines (norepinephrine and dopamine) concentration due to exercise 
has been proposed to lead to faster processing (McMorris, Sproule, Turner, & Hale, 
2011). Catecholamines activate the reticular formation and increase arousal. More 
specifically, P3 latency which measures the speed of stimulus classification and stimulus 
evaluation time (Kamijo et al., 2007), shows a decreased latency post exercise (Gerin & 
Privat, 1998; Travlos & Marisi, 1995). Deceased P3 latency plays a role in working 
memory RT partly explaining how exercise improves it.  
Moderate-intensity exercise improves blood flow and oxygen to the brain (Ide & Secher, 
2000) causing improvements in various cognitive tasks (Meeusen & De Meirleir, 1995; 
Polich & Kok, 1995). Exercise also improves cortical activation, which as 
aforementioned, is an important part of cognitive functioning. Exercise activates key 
brain areas associated with attention and memory performances. It was revealed that 
exercise activates dorsolateral prefrontal cortices in both hemispheres and the left 
dorsolateral prefrontal cortex during Stroop Test performances (Yanagisawa, Dan, 
Tsuzuki, Kato, Okamoto, Kyutoku & Soya, 2010). This activity correlated with improved 
performances on the test indicating exercises effect on cognition is partly mediated via 
enhanced prefrontal cortex activation. A study looking at brain activity during the N-back 
task post exercise showed increased brain activation in several brain regions (Li, Men, 
Chang, Fan, Ji, & Wei, 2014). Functional MRI showed increased activation in the right 
middle prefrontal gyrus, the right lingual gyrus, and the left fusiform gyrus and decreased 
activation in the anterior cingulate cortexes, the left inferior frontal gyrus, and the right 
paracentral lobule during the harder task (2-back). Although there was a difference in 
brain firing post exercise, n-back scores were not significantly different. This could be 
attributed the study having a small sample size (n = 15). Furthermore, this study might 
have experienced a ceiling effect, as the 2-back task might not be hard enough. Lastly, 
there was greater activation in the brain during the 2-back condition compared to the 0-
back condition. These brain regions are thought to be responsible for solving complex 
tasks. 
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Brain-derived neurotrophic factor (BDNF) plays an important role in neural development, 
functioning, neurogenesis and affects learning and memory performances (Szuhany, 
Bugatti, & Otto, 2015). This protein is found in high concentration throughout the central 
nervous system, including brain regions such as the hippocampus, cerebral cortex, 
hypothalamus and cerebellum (Murer Yan, & Raisman-Vozari, 2001). BDNF activity has 
been suggested to mediate the effects of exercise on cognition as it increases post 
exercise (Zoladz, Pilc, Majerczak, Grandys, Zapart-Bukowska, & Duda, 2008). Higher 
levels of BDNF have also been associated with improved cognitive task performances 
(Szuhany et al., 2015) while lower levels in older adults may contribute to memory 
impairments. Exercise-induced BDNF also reduces the threshold for encoding and 
memory (Intlekofer et al., 2013) putting the brain in a state of readiness for plasticity  
(Cotman, Berchtold, & Christie, 2007).  
1.9 Working Memory 
Working memory is an aspect of cognition worth focusing on as it plays a key role in 
goal-oriented behaviour and complex decision making (Baddeley, 1998; Bryan & Luszcz, 
2001; Park, Smith, Lautenschlager, Earles, Frieske, Zwahr, & Gaines 1996). By 
interacting with the central executive mechanism, the phonological loop, and the 
visuospatial sketchpad (Baddeley, 1998), working memory provides temporary memorial 
representations. The phonological loop encodes verbal and acoustic info while the 
visuospatial sketchpad encodes visual and visuospatial information. The central executive 
is responsible for overseeing the whole process and ensuring information held in the 
short-term memory, and long-term memory is integrated. This study focuses on working 
memory as it plays a prominent role in everyday functioning (Heaton et al., 2004). For 
instance, working memory is needed for military, sport, and academic performance 
(Alloway, & Alloway, 2010; McMorris et al., 2011) and training working memory can 
improve fluid intelligence (Jaeggi, Studer-Luethi, Buschkuehl, Su, Jonides, & Perrig, 
2010). Furthermore, exercise and nicotine are more likely to affect performances on 
working memory tasks than other simple cognitive tasks.  
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Several brain regions are consistently activated during n-back tasks including: the lateral 
premotor cortex, dorsal cingulate and medial premotor cortex, dorsolateral and 
ventrolateral prefrontal cortex, frontal pole and bilateral and medial posterior parital 
cortex (Owen, McMillan, Laird, & Bullmore, 2005). These regions in general, implicate 
executive processes and performance in working memory tasks. Furthermore, the 
prefrontal cortex seems to have the biggest impact on working memory as several regions 
within the prefrontal cortex plays a prominent role in working memory performances.  
 Working memory is impacted negatively during a quit attempt (Jacobsen et al., 2007; 
Ashare et al., 2014; Snyder & Henningfield 1989) and nicotine can reverse the harmful 
effects of nicotine deprivation (Atzori et al., 2008; Ashare & McKee 2012). Nicotine 
administration and working memory research has produced equivocal findings.  Some 
studies have shown positive effects in smokers (Ernst, Heishman, Spurgeon, & London, 
2001; Grundey et al., 2015; Grobe, Perkins, Goettler-Good, & Wilson, 1998; McClernon, 
Gilbert, & Radtke, 2003; Myers et al., 2008) and non-smokers (Heishman et al., 2010; 
Kumari et al., 2003; McClernon et al., 2003; Mumenthaler, Taylor, O’Hara, & Yesavage, 
1998), while others have shown no effects (Ernst et al., 2001; Foulds, Stapleton, 
Swettenham, Bell, McSorley, & Russell, 1996; Heishman et al., 1993; Hindmarch, Kerr, 
Sherwood, 1990; Kleykamp et al., 2005), and few have shown negative effects (Foulds et 
al., 1996; Grundey et al., 2015). There are currently no (a) standard nicotine dosages or 
form of administration and (b) uniformly accepted ways to assess working memory, 
which likely contribute to these inconsistent findings (Ernst et al., 2001). With respect to 
exercise, many studies have shown the positive effects of a single bout of exercise on 
working memory tasks (Churchill et al., 2002; McMorris et al., 2011; Williams & Lord, 
1997); however, there is also no standard exercise dose (intensity and duration). 
1.10 Nicotine vs. Exercise on Cognitive Performance 
(Working Memory) 
As discussed above, nicotine has been shown to have a positive effect on cognitive 
performance in both smoking and non-smoking models, whereas exercise has been 
shown to have the same positive effect in non-smoking models only. There is no 
evidence that nicotine is superior to exercise in enhancing cognitive performance (i.e., 
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working memory) in either smoking or non-smoking model. 
1.11 Purpose and Hypothesis 
Purpose 
The purpose of the present study was to examine whether a 20 min bout of moderate-
intensity exercise enhances cognitive performance (working memory) as effectively as 4 
mg of NICORETTE® gum in a non-smoker population. 
Hypothesis 1 
All participants will improve working memory performance after nicotine and exercise 
treatment. 
Hypothesis 2 
There will be no significant difference in working memory performance between nicotine 
and exercise treatments. 
1.12 Implications of this study  
Nicotine’s effect on humans is undeniable. Aside from being an addictive psychoactive 
drug, it can also improve cognition. This cognitive boost could play a role in introducing 
non-smokers to smoking and even maintain this habit down the road. The cognitive 
effects of nicotine also impact special populations. Nicotine has been used to aid 
unhealthy populations to attenuate attention and cognitive deficits found in schizophrenia, 
Alzheimer’s, ADHD, Parkinsons’s diseases and other age-related cognitive decline 
(Evans & Drobes 2009; Levin et al., 2006; Newhouse et al., 2004). If exercise improves 
cognitive performance similarly to nicotine, it will gain support and credibility as a 
possible treatment aid for special populations while providing healthy non-smokers with 
a safe alternative.  
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Chapter Two: The Current Study 
Ethics Statement  
The experimental procedure was approved by the Western University Health Science 
Research Ethics Board (HSREB) and met the standards of the Declaration of Helsinki. 
Each participant was informed of the discomfort associated with acute exercise and 
nicotine before providing written informed consent.  
2.1 Methods 
Participants 
The sample group for this study consisted of healthy male and female non-smokers 
(N=36). Participants were students from Western University and were recruited through 
posters placed across campus. Demographic data can be found in Table 2. Upon 
completion, participants received a $10 gift card to a local store. Inclusion criteria 
required participants be: (a) non-smoker; (b) aged 18-45 years; (c) right-handed; (d) have 
no contraindications to physical activity; and (e) no contraindications to nicotine. 
Exclusion criteria included: (a) dealing with a mental illness; (b) females who were 
pregnant or breastfeeding; (c) currently or recently smoked cigarettes; and (d) having 
major health complication. The 18-45 age range ensured this sample included the group 
with highest potential tobacco use (20-34 years) (Statistics Canada, 2014), Participants 
were removed from the dataset due to: dropouts (n=9), uncomfortable with nicotine 
(n=2), outside age criteria (n=1), and dealing with mental illness (n=1). The final sample 
size included twenty-three participants (Mage = 25.87, SD = 8.058. 13 female). Five 
reported smoking a cigarette at one point in their life, and only one was a previous 
smoker.  
Design 
This study employed a randomized, within-subjects counterbalanced procedure trial 
design. The sample was stratified by gender and was randomly assigned to conditions 
using a random number generator (www.randomizer.org). A graphic illustration of the 
study design can be found in Figure 2.  
2.2 Primary Outcome Measure 
Cognitive performance.  
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Working memory was measured using the N-back task (Jonides, Schumacher, Smith, 
Lauber, Awh, Minoshima, & Koeppe, 1997). The N-back task is a measure of working 
memory as it requires the use of both the phonological loop and the visuospatial 
sketchpad (Jonides et al., 1997). The N-back was performed on a laptop in an isolated 
room using INQUISIT By Millisecond Software (version 4.0.8.0). There were four 
different cognitive loads 0, 1, 2, and 3-back each increasing in difficulty. These loads 
occur in a random order. Each trial takes approximately 5 min to complete and involves a 
letter stimulus that appears on a computer screen for an interval of 500 ms, followed by a 
1000 ms blank screen interstimulus. Participants see a total of 200 letters in the 5 minute 
task (0-back = 48 letters, 1-back = 48 letters, 2-back = 50 letters, 3-back = 54 letters). 
Participants had to determine if the stimuli matched the stimuli that appeared “N” items 
back and were instructed to press the response key (‘A’ key) using their right hand as 
soon as a target appears while keeping in mind both the speed and accuracy components 
of the task. In the 1-back condition, the target is defined as the letter stimulus that is the 
same as the one preceding it. For example, “x, interstimulus, x” would be the target. In 
the 2-back condition, the target is defined as a letter appearing that is the same as what 
preceded it two letters before. For example, “a, interstimulus, b, interstimulus, a”, would 
be the target (see Figure 1 for N-back illustration). The 3-back letter condition was 
treated as the primary outcome measure as it is most sensitive to behaviour and 
medication effects (Loughead et al., 2009). Performances on the N-back were assessed by 
recording the number of errors committed (Accuracy) and mean reaction time (RT) in 
milliseconds for each N-back condition. As previously mentioned, cognitive performance 
(working memory) was the focus of this study because it is affected by nicotine in both 
smokers and non-smokers (Kumari et al., 2003; Heishman et al., 2010) and exercise in 
non-smokers (McMorris et al., 2011). Furthermore, performances on the 3-back are 
influenced by acute exposure to nicotine (Heishman et al., 1994). 
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Figure 1. Diagram of the four N-back conditions (Braver, Cohen, Nystrom, 
Jonides, Smith, & Noll, 1997). 
2.3 Other Measures 
Vital signs 
Heart rate and systolic/diastolic blood pressure were recorded to monitor the effect of 
nicotine gum and exercise. There were three measure points: before treatment, right after 
treatment, and after the N-back task. Heart rate was monitored using the Polar RS100 
heart rate device and systolic/diastolic blood pressure was measured manually. 
Sociodemographic Questionnaire  
Information, including: age, gender, and contact information was collected. 
Physical activity readiness questionnaire 
The standard seven-item questionnaire was used to assess if participants required medical 
clearance to engage in physical activity (PAR-Q; Canadian Society for Exercise 
Physiology [CSEP], 2012). Participants were required to response yes or no to the 
questions; if they responded yes to any items they were ineligible to participate. 
Smoking History & Current Practices 
Participants past smoking history and habits were collected. 
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Exercise Behaviour 
The Godin Leisure-Time Exercise Questionnaire was used to assess leisure-time physical 
activity (Godin, & Shephard, 1997). This brief four-item questionnaire breaks down the 
amount of mild, moderate and strenuous exercise participants engaged in during their free 
time and how often their heart beats rapidly. 
2.4 Intervention 
Moderate-intensity exercise 
Moderate intensity was defined as 45 to 68% of heart rate. Moderate-intensity was 
calculated using the formula: (220 – age) x 60~70% of heart rate, as this intensity 
improves multiple aspects of cognitive function (Chang, Tsai, Hung, So, Chen, Etnier, 
2011; Hillman, Snook, & Jerome, 2003). Participants completed a 20 min bout of 
moderate-intensity exercise on a Woodway PPS treadmill (Woodway, Waukesh, WI). 
This bout entailed a 5 min warm up to start and 3 min cool-down to end. Participants’ 
heart rate was monitored closely using the Polar RS100 heart rate device. The researcher 
controlled the incline and speed corresponding to participants’ heart rate ensuring they 
were exercising at a moderate-intensity while allowing participants to decide whether 
they would rather have the speed or incline manipulated when needed. As previously 
mentioned this intensity of exercise has been shown to have the best results on cognitive 
performance including working memory (Kamijo et al., 2007 Gondola, 1987; Heckler & 
Croce, 1992; Sibley et al., 2006; Tomporowski, 2003). Moderate-intensity exercise is 
also easy enough to be done by untrained individuals. 
Nicotine gum  
Participants received two pieces of nicotine polacrilex  (Nicorette®) gum. Each piece 
contained 2 mg of nicotine. Nicotine polacrilex was chosen due to ease of administration 
and controlled mean of delivery when administrated under the standardized chewing 
protocol (Henningfield, Radzius, Cooper, & Clayton, 1990). This protocol reduces 
individual response variability and plasma nicotine levels directly relate to the dose. Thus 
participants were instructed to chew once every 3 seconds for 20 min as almost 50% of 
the nicotine remains in the gum if not chewed properly (Benowitz, Jacob, & Savanapridi, 
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1987). Lastly, nicotine gum was picked as it has low dependence potential and toxicity 
(USDHHS, 1988) 
2.5 Procedure 
Individuals who expressed interest and contacted investigators were screened for 
eligibility criteria by telephone or e-mail. Screening questions concerned smoking status, 
age, contraindications to nicotine or exercise, dominant hand, mental illness and for 
females current pregnancy or breastfeeding. If eligible, the researcher then scheduled the 
first lab visit. The study required participants to come to the Exercise and Health 
Psychology Laboratory (EHPL, ww.ehpl.uwo.ca) at the University of Western (London, 
Ontario) for three sessions, baseline, first treatment, and second treatment. 
Upon arriving at the lab, participants read the letter of information and offered signed 
consent followed by the sociodemographic questionnaire, PAR-Q, and Godin Leisure-
Time Exercise Questionnaire. Participants were restricted to half a cup of coffee on each 
day of testing and instructed to abstain from alcohol and drugs for at least 24 hours before 
testing. Participants were then randomized into two equal treatment groups of either 
nicotine administration, or exercise participation, and then switch to counterbalance 
treatments. During baseline (Visit 1), participants were familiarized with the N-back task 
until they could consistently score 75% or higher in each N-back trial to eliminate any 
learning effect. Participants were instructed to perform the task as accurately as they can 
while keeping reaction time in mind. Once competency was established, a baseline 
cognitive measure was obtained from each participant utilizing the N-back test. Each visit 
was scheduled at seven days intervals, and participants were notified the night before 
testing as a reminder of instructions and protocol for the given task. Time of day that 
subjects participated in was kept constant. For the second visit, participants were 
randomized into one of two treatments (nicotine or exercise) and began the N-back 
immediately after treatment (within 2 min). Participants then returned for a third visit one 
week later and underwent the treatment condition (i.e. exercise or nicotine) they had not 
done yet. After completion of the third visit, participants were thanked and received their 
compensation (see Figure 2).  
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Figure 2. Flow diagram of participants moving through the study.  
Recruited and initial screening
Baseline Visit:
Participants performed the n-
back test
Visit 2:
Randomized into exercise 
treatment
Performed N-back post 
exercise 
Visit 3:
Randomized into nicotine 
treatment
Performed N-back post 
nicotine
Visit 2:
Randomized into nicotine 
treatment
Performed N-back post 
exercise 
Visit 3: 
Randomized into exercise 
treatment
Performed N-back post 
exercise
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2.6 Statistical Analyses 
Manipulation check (treatment) 
Paired samples t-test was conducted to compare baseline heart rate and systolic/diastolic 
blood pressure to post-treatment heart rate and systolic/diastolic blood pressure. 
Primary outcome analyses 
Separate repeated measure MANOVAs (3 treatment conditions: baseline, nicotine, 
exercise) were conducted to examine the effects of treatment on N-back accuracy and 
RT. Significant main effects were followed by all possible pairways comparisons sample 
t-tests. MANOVA was chosen over ANOVA as the latter is susceptible to violations of 
sphericity (variances of the differences between all possible pairs of groups or conditions 
are equal) as indicated by Mauchly’s Test of Sphericity (Stevens, 1996). 
The level of significance was accepted at p < .05 for all tests (Tabachnick & Fidell, 
1996). Effect sizes (η 2) accompany all reported findings. In accordance with Cohen 
(1988), 0.02 is a small effect size, 0.13 is a moderate effect size, and 0.26 is a large effect 
size. Data was analyzed using IBM SPSS Statistics (Version 24). 
 
Table 2: Demographic Variables at Baseline 
 
 
 
 
 
 
 
 
 
    
Variable M SD % 
Gender (Female) 
Age (Years) 
Physical activity (Weekly 
frequencies)* 
   Strenuous 
   Moderate 
   Mild 
Total weekly leisure 
activity (METs) 
 
25.87 
 
 
3.91 
3.43 
2.09 
63.61 
 
8.06 
 
 
4.33 
2.63 
2.04 
56.52 
*Bouts must be over 15 minutes     
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2.7 Results  
Manipulation Check 
Exercise 
Paired t-test showed that there was significant increase in heart rate t(22) = -13.855, p 
< .001, η2=0.90 and systolic blood pressure t(21) = -6.074, p < .001, η2=0.64  after 
engaging in moderate intensity from baseline to post-exercise. Diastolic blood pressure, 
however, was not significantly different t(21) = 1.125, p = .273, η2=0.06. 
Nicotine 
Paired t-test showed that there was significant increase in heart rate t(20) = -5.545, p 
< .001, η2=0.60  and diastolic blood pressure t(20) = -2.946, p = .008, η2 = 0.30  after 
nicotine administration from baseline to post-exercise. Systolic blood pressure, however, 
was not significantly different t(20) = .169, p = .868, η2 = 0.001.   
Primary Outcome 
3-Back Accuracy 
Repeated measure MANOVA revealed a significant treatment effect on accuracy Wilks’ 
Lambda = .536, F (2, 21) = 9.104, p = .001, partial eta square η2 = .464. These findings 
suggest that there was as a change in accuracy across the 3 treatment conditions. Post-hoc 
comparison revealed a significant difference in the scores for baseline (M = 8.00, SD = 
2.468) and exercise (M = 5.52, SD = 3.043) conditions—t(22) = 4.357, p < .001, η2=0.46; 
no significant difference in the scores for baseline (M = 8.00, SD = 2.468) and nicotine 
(M = 7.48, SD = 2.842) conditions—t(22) = .866, p = .396, η2=0.03 and; a significant 
difference in the scores for exercise (M = 5.52, SD = 3.043) and nicotine (M = 7.48, SD = 
2.842) conditions—t(22) = 2. 567, p = .012, η2= .25. (see Figure 3). 
3-Back RT 
 Repeated measure MANOVA revealed a significant treatment effect on reaction time 
Wilks’ Lambda = .667, F (2, 21) = 5.232, p = .014, partial eta square η2 = .333. These 
findings suggest that there was a change in RT across the 3 treatment conditions. Post-
   
 
 
22
hoc paired sample t-tests indicated that there was a significant difference in the scores for 
baseline (M=810.27, SD=209.801) and exercise (M = 710.64, SD = 181.948) 
conditions—t(22) = 3.204, p = .004, η2=0.31; for baseline (M = 810.27, SD = 209.801) 
and nicotine (M = 708.99, SD = 187.469) conditions—t(22) = 3.099, p = .005, η2=0.30; 
but not for exercise (M = 710.64, SD = 181.948) and nicotine (M = 810.27, SD = 
209.801) conditions—t(22) = 0.087, p = .931, η2= .00034. (see Figure 4).  
Secondary Outcome 
0-2 back 
0-back accuracy. Repeated measures MANOVA revealed a non-significant treatment 
effect on reaction time Wilks’ Lambda = .937, F (2, 21) = .704, p = .506, partial eta 
square η2 = .063. 
1-back accuracy. Repeated measures MANOVA revealed a non-significant treatment 
effect on reaction time Wilks’ Lambda = .933, F (2, 21) = .755, p = .482, partial eta 
square η2 = .067. 
2-back accuracy. Repeated measures MANOVA revealed a non-significant treatment 
effect on reaction time Wilks’ Lambda = .785, F (2, 21) = 2.871, p = .079, partial eta 
square η2 = .215. 
0-back RT. Repeated measures MANOVA revealed a non-significant treatment effect on 
reaction time Wilks’ Lambda = .942, F (2, 21) = .647, p = .534, partial eta square η2 = 
.058.  
1-back RT. Repeated measures MANOVA revealed a non-significant treatment effect on 
reaction time Wilks’ Lambda = .800, F (2, 21) = 2.631, p = .096, partial eta square η2 = 
.200.  
2-back RT. Repeated measures MANOVA revealed a significant treatment effect on 
reaction time Wilks’ Lambda = .719, F (2, 21) = 4.105, p = .031, partial eta square η2 = 
.281. These findings suggest that there was a change in RT across the 3 treatment 
conditions. Post-hoc paired sample t-tests indicated that there was a significant difference 
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in the scores for baseline (M=678.53, SD=204.390) and nicotine (M=618.56, 
SD=160.477) conditions— t(22)=2.932, p = .008, η2=0.28; but not for baseline (M = 
678.53, SD = 204.390) and exercise (M = 638.30, SD = 233.344) conditions— 
t(22)=1.032, p = .313, η2=0.046; or for exercise (M = 638.30, SD = 233.344) and nicotine 
(M=618.56, SD = 160.477) conditions— t(22)=0.539, p = .596, η2= .015. 
Table 3: Means, Standard Deviations, and 95% Confidence Intervals for 0-2 N-back 
 
 
Trial 
Mean SD 95%CI  
Baseline 
   0-back RT 
 
472.90 
 
56.05 
 
[448.66, 497.13] 
   1-back RT 551.76 127.56 [496.60, 606.92] 
   2-back RT 678.53 204.39 [590.145, 766.91] 
   0-back Accuracy 1.22 1.95 [.37, 2.06] 
   1-back Accuracy 
   2-back Accuracy 
Exercise 
   0-back RT 
   1-back RT 
   2-back RT 
   0-back Accuracy 
   1-back Accuracy 
   2-back Accuracy 
Nicotine 
   0-back RT 
   1-back RT 
   2-back RT 
   0-back Accuracy 
   1-back Accuracy 
   2-back Accuracy 
.65 
2.87 
 
461.36 
536.53 
638.30 
.78 
1.09 
1.87 
 
469.15 
513.36 
618.56 
     1.57 
1.00 
2.61 
1.19 
2.44 
 
82.62 
160.91 
233.34 
1.62 
1.31 
2.75 
 
118.42 
130.78 
160.48 
2.98 
1.28 
2.86 
[.14, 1.17] 
[1.81, 3.92] 
 
[425.63, 497.09] 
[466.95, 606.12] 
[537.39. 739.20] 
[.08, 1.48] 
[.52, 1.65] 
[.68, 3.06] 
 
[417.94, 520.35] 
[456.81, 569.92] 
[549.16, 687.96] 
[.27, 2.85] 
[.45, 1.55] 
[1.37, 3.84] 
   
 
 
24
 
Figure 3. Mean accuracy scores at each time point. Error bars represent 
standard error. Each condition included 54 letter stimuli. 
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Figure 4. RT score at each time point. Error bars represent standard error.  
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Chapter Three: Discussion 
To the author’s knowledge, this is the first study to investigate the effectiveness of an 
acute bout of moderate-intensity exercise versus 4 mg nicotine polacrilex gum on 
cognitive performance (i.e., working memory) in a non-smoking population. Participants 
underwent both treatments in a randomized counterbalanced fashion. Our main finding 
showed significant improvement in RT after both treatments. Accuracy significantly 
improved only for exercise. Beyond theses general findings a number of specific issues 
warrant commentary.  
Accuracy in the exercise condition improved by 31.25% but only 6.5% in the nicotine 
condition. This 26.4% net difference indicates that exercise was superior to nicotine in 
enhancing cognitive performance (i.e., working memory). Although previous literature 
supports exercise facilitating cognitive performance (Chang et al., 2012; Lambourne & 
Tomporowski, 2010; McMorris & Hale, 2012), the effects reported were smaller to the 
ones reported here. This raises the question why? One plausible reason is that the dose 
(i.e., duration = 20 minutes and intensity = 45-68% of heart rate) of exercise was optimal 
for enhancing cognitive performance in the present study. As previously mentioned, short 
exercise sessions (< 10 min) show negligible cognitive performance effects while 
exercise bouts over 11 min show significant effects (Chang et al., 2012). Superior 
cognitive improvements also have been shown with moderate intensity exercise (Kamijo 
et al., 2007). Fitness level seems to play a major role in exercises’ effect on cognitive 
performance (Chang et al., 2012) as highly fit participants appear to benefit the most 
while less-fit participants might suffer adverse effects. This is because unfit participants 
are more likely to reach exhaustion faster, which is associated with impaired cognitive 
performance (Brown & Bray, 2014).  It is important to acknowledge that participants in 
this study were self-selected opening the possibility they exercise regularly or enjoy 
exercise. Finally, the N-back task that was selected to capture working memory accuracy 
may, in part, help explain these findings. Although past research has shown that the entire 
N-back protocol is sensitive to accuracy change by both acute exercise (Audiffren, 2009; 
Tomporowski, 2003) and nicotine (Heishman et al., 2010), the focus of the present study 
was on the 3-back (the most difficult and challenging task). It was suspected and 
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confirmed that 0-2 back conditions would be too easy for participants creating a ceiling 
effect, and thus negating treatment effects. The 3-back was also selected as it is sensitive 
to behavior and medication effects (Loughead et al., 2009), It should also be mentioned 
that the modest accuracy improvement found for nicotine is not consistent with effects 
reported for memory type tasks in the Heishman et al. (2010) meta-analysis.  
RT improved by 12.34% in the exercise condition and 12.59% in the nicotine condition. 
This 0.25% net difference indicates that both treatments were equally effective in 
enhancing working memory RT. This finding is in line with previous literature. Past 
studies have typically reported large effect sizes for both exercise (Chang et al., 2012) 
and nicotine (Heishman et al., 2010). Furthermore, arousal has been shown to decrease 
RT (Eason, Harter, & White, 1969). Both treatments in this study are known to increase 
arousal (Fan et al., 2005; Gilbert et al., 2000; McMorris et al., 2011; Perkins et al., 1994; 
Perkins et al., 1996; Posner & Rothbart, 2007). Therefore, shorter RT is expected post-
treatment.  
Working memory tasks like the N-back provide accuracy and reaction time (RT) scores. 
Although there is a well-known speed-accuracy trade-off effect (performing a task faster 
jeopardizes its accuracy (Reed, 1973), this was not the case in either treatment as both 
showed decreased RT (12.34% for exercise and 12.59% for nicotine) while improving 
accuracy (31.25% for exercise and 6.5% for nicotine). The author argues accuracy data 
are more important in these types of tasks. Performing a cognitive task faster has little 
implication if accuracy is jeopardized. For example, it is more important to get the correct 
answer on an exam than to finish quickly.  
Nicotine-induced enhancement might have been jeopardized as a consequence of 
dysphoria non-smokers experience (Heishman, et al., 1993; Hindmarch et al., 1990). 
Heishman and Henningfield (2000) sought to explore this idea by developing tolerance to 
the initial dysphoric effects of nicotine in non-smoker participants. Participants received 
ascending doses of nicotine (0, 2, 4, 8 mg) for eight consecutive days. At the end of the 
eight days, participants showed tolerance to the initial dysphoric effects of nicotine. 
Despite the tolerance manipulation, reaction time on working memory was the only 
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measure that improved while working memory accuracy, gross motor coordination, 
recognition, and visual scanning and attention were impaired. The findings from the 
present study suggests, any dysphoria non-smokers experience post nicotine is not 
adversely affecting cognitive task performances (i.e., accuracy). Furthermore, impairment 
seen in the Heishman and Henningfield study might have been due to the nicotine dose 
itself. Participants received 0, 2, 4, and 8 mg of nicotine gum causing plasma nicotine 
concentration levels to be as high as 6.9-11.5 ng/ml. Even after building tolerance, a 14 
mg dose might be too high for non-smokers and could negatively impact cognitive 
performance.  
3.1 Strengths and Limitations  
There are several strengths that must be highlighted with the present study. First, a 
randomized counterbalanced trial design allowed every participant to undergo both 
treatments and serve as their own control. Using a randomized counterbalanced 
procedure guarded against practice or order of treatment effects.  Furthermore, this design 
protected against any loss of motivation participants might experience causing them to try 
less in later visits. As this was a within-subject design, it had greater power and reduced 
error variance associated with individual difference (Pollatsek & Well, 1995). This in 
turn allowed the author to use a smaller number of participants to explore the 
effectiveness of the two treatments compared to a between subject design. Second, 
participants’ level of caffeine and alcohol consummation was controlled. Caffeine is 
known to increase feelings of concentration and alertness (Peeling & Dawson, 2007) and 
has been shown to enhance N-back performance depending on personality type-
extraversion (Smillie & Gökçen, 2010). Alcohol is known to impair many types of 
cognitive function including working memory (Dry, Burns, Nettelbeck, Farquharson, & 
White, 2012). Additionally, coffee consumption can limit nicotine absorption 
(Henningfield et al., 1990). Ensuring these two were not consumed the day of testing 
(caffeine) and within 24 hours of testing (alcohol) played an instrumental role in assuring 
changes in performances were due to treatment rather than uncontrolled substance factors. 
Third, there was a manipulation check using HR and blood pressure data to ensure the 
two treatments were properly received. Past research shows nicotine significantly 
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increases diastolic blood pressure and heart rate (Ernst et al., 2001; Foulds et al., 1997; 
Hughes, Rose, & Callas, 2000; Ragueneau, Michaud, Démolis, Moryusef, Jaillon, & 
Funck‐Brentano, 1999) while systolic blood pressure and heart rate increases due to 
exercise (Shahraki, Mirshekari, Shahraki, Shahraki, & Naroi, 2012). Lastly, the dose of 4 
mg was picked, as 2 mg is not intense enough to produce all the physical symptoms of 
nicotine while stronger doses lead to higher reports of dysphoria (Kleykamp et al., 2005). 
Despite the strengths highlighted, the present study is not without limitations. First, only 
one domain of cognitive performance (i.e., working memory) was examined. Thus it is 
unclear whether the effect is universal or only specific to working memory assessed 
through the N-back. Furthermore, although the N-back has strong face validity it has 
been shown to have weak convergent validity with other measures of working memory 
(Kirchner, 1958; Kane, Conway, Miura, & Colflesh, 2007). Second, with only twenty-
three participants, these findings may not be generalizable to other non-smoking 
populations.  Third, although participants were given specific chewing instructions, there 
is no way of knowing whether they followed instructions as they sat in a room alone for 
the 20 min. This is problematic as almost 50% of the nicotine remains in the gum with 
improper chewing (Benowitz, Jacob, & Savanapridi, 1987). However, although plasma 
nicotine levels were not recorded in this study, heart rate and diastolic blood pressure 
manipulation check indicate the nicotine treatment worked. N-back performances were 
enhanced post-nicotine further supporting this treatment. The question remains whether 
nicotine-induced improvements were maximized using the current procedure. If 
participants failed to follow the chewing procedure, they might have received enough 
nicotine to show a partial effect only. RT improved by 12.59% while accuracy only 
improved by 6.5%. These effects might underrepresent the effect of 4mg nicotine gum 
and further cognitive benefits could have resulted from the full dose. Fourth, neither the 
researcher nor the participant was blinded to the treatment. Fifth, this study did not 
measure the typical dysphoria or negative mood nicotine typically produces in non-
smokers (Heishman et al., 1993). Sixth and finally, participants’ prior knowledge 
regarding treatment was also not measured. Hence, the author cannot rule out whether 
expectancy effects influenced the overall findings.  
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3.2 Future Directions 
The results obtained in this study needs to be replicated with a larger non-smoking 
sample. An important future direction is conducting this study with a smoking 
population. Since abstinent smokers experience cognitive deficits, it would be interesting 
to see whether exercise-induced improvement is robust enough to reverse this impairment 
and show additional improvement.  
As aforementioned, only one cognitive domain was examined. Future studies need to 
discover if exercise improves other domains more effectively than nicotine gum can. In 
the 2010 meta-analysis regarding nicotine’s effect on cognitive performances, thirteen 
domains were classified, and only six of those domains showed significant positive 
effects post administration (Heishman et al., 2010). Performances in all thirteen domains 
need to be examined post exercise. More importantly, the other five domains that 
improved post nicotine administration need to be tested post exercise to see which 
treatment is more effective on different types of cognition. Tasks like short-term episodic 
memory accuracy and alerting attention show the greatest improvement post nicotine 
administration making them potential candidates for future studies to examine. 
Cognitive testing occurred immediately after treatment (approximately 2 min). This study 
did not examine whether treatment effects are present after a delay. Exercise has been 
shown to demonstrate its biggest effects on cognition 11-20 min after exercise, but these 
effects wane after delays longer than 20 min (Chang et al., 2012). Nicotine’s delayed 
enhancement effect has been observed in animal models and can last 24 h after 
administration (Buccafusco, & Jackson, 1991; Buccafusco, Jackson, Jonnala, & Terry, 
1999). Nicotine’s delayed effect on human cognition, however, has yet to be examined. 
Future work needs to evaluate the effect of these two treatments in delayed testing 
models.  
Another worthwhile line of inquiry is to clarify whether acute exercise and nicotine gum 
function through distinct mechanistic pathways. Imaging (brain scans) procedures may 
prove useful in identifying how exercise and nicotine exert their effect on cognitive 
performance. As previously mentioned, research has implicated overall cortical activity 
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in both treatments as one possible mechanism behind this effect (Grundey et al., 2013; Li 
et al., 2014; Yanagisawa et al., 2010). Correspondingly, enhanced intracortical 
facilitation in the prefrontal cortex is associated with improved working memory 
performance (Brunoni & Vanderhasselt, 2014), and there is a substantial amount of 
nicotinic receptors in the prefrontal functions. (Poorthuis & Mansvelder 2013). An 
advantage exercise has over nicotine is the ability to provide the brain with BDNF 
proteins which plays an essential role in learning and memory performances (Szuhany et 
al., 2015). This protein is released after exercise bouts and helps improve cognitive 
performances (Szuhany et al., 2015; Zoladz et al., 2008). There has been some evidence 
that nicotine administration leads to increases in BDNF mRMA expression in the dorsal 
hippocampus (Wei, Liu, Li, Zheng, Zhou, & Li, 2015). Evidence, however, remain 
minimal and more studies need to explore the role of nicotine and BDNF in human 
cognition. 
Although the two treatments rely on the same brain region-prefrontal cortex-they could 
use different pathways allowing possible additive effect. With respect to additive effects, 
two studies have investigated the possibility of using acute exercise and NRT to alleviate 
cravings and withdrawal symptoms in a smoking model (Harper et al., 2012; Tritter, 
Fitzgeorge, & Prapavessis, 2015). Harper et al. found that combining acute exercise and 
the NRT patch led to extra cravings relief throughout the duration of the study (9 weeks 
post-quit). Withdrawal symptoms benefited from an additive effect up to the 7-week 
mark. This study, however, did not employ a control group leaving it open to criticism. 
The second study sought to validate this by adding a control group in an acute model.  
Smokers abstained for 15 h and were randomized into their conditions and receiving a 2 
mg nicotine lozenge (Tritter et al., 2015). Those in the experimental condition partook in 
a 20 min moderate-intensity exercise bout while the control condition sat passively. The 
experimental group (which received both treatments) had lower craving scores at each 
time point. Withdrawal symptoms were reduced in both groups, but there was no 
evidence of any additive effect. This study did include a subjective assessment of 
concentration. Although this measure did improve, there was no visible additive effect of 
the two treatments. Future studies need to examine the possibility of any additive 
cognitive effects directly, as subjective reports are not always reliable. Furthermore, 
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concentration levels might experience a ceiling effect. Hence, a more sophisticated 
cognitive task is essential in exploring additive effects in future studies. 
3.3 Implications  
Nicotine has been suggested as medication in unhealthy populations dealing with 
cognitive deficits (Barr et al., 2008; White & Levin 1999; Wilson et al., 1995). This 
research indicates that exercise is a more effective and efficient treatment regarding 
cognitive functioning. Benefits of using a treatment like exercise include avoiding 
exposing these populations to an addictive drug like nicotine while exposing them to the 
countless health benefits exercise delivers (Clark & Uraina, 2011).  Exercise enhances 
weight control, reduces the risk of cardiovascular disease, red type 2 diabetes, 
osteoporosis, as well as breast and colon cancers.  
Young adult stress is associated with the decision to commence smoking (Byrne, Byrne, 
& Reinhart, 1995). This stress typically arises from school performance and future 
uncertainty, as academic success can determine future occupation. Consequently, 
adolescents turn towards smoking to help them cope. Alongside nicotine’s addictive 
effect, the cognitive boost it provides could reinforce this behaviour and help relief 
academic related stress if it translates to better grades. Moderate-intensity exercise can 
reduce stress (Hansmann, Hug, & Seeland, 2007; Jin, 1992) and has been shown to 
enhance cognitive performance (Chang et al., 2012). The findings from the present study 
can be used to convince the non-smoking population to look to healthy behaviours like 
exercise when facing stressful situations or cognitive lulls. Furthermore, smoking and 
exercising are incompatible behaviours as reported high leisure-time exercise levels are 
inversely related to smoking in self-reported surveys (Boutelle, Murray, Jeffery, 
Hennrikus & Lando, 2000). Therefore, exercising could further protect young adults from 
taking up smoking. 
Eighty-five percent of Canadians do not meet the current Canadian Physical Activity 
Guidelines (Colley, Garriguet, Janssen, Craig, Clarke, & Tremblay, 2011) meaning most 
people are missing out on exercises-induced benefits in cognition and health in general. 
The results from this study might encourage people (students specifically) to begin 
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exercising to receive cognitive benefits. If regular exercise becomes habitual at a younger 
age, it could carry on into adulthood helping with the lack of exercise epidemic. 
3.4 Conclusion 
This is the first study directly examining the effectiveness of exercise and nicotine on 
cognitive performance (i.e., working memory) in non-smokers. Findings showed 
significant improvements in RT after both treatments. However, accuracy significantly 
improved only for exercise. The author recommends exercise over nicotine as a safe and 
effective strategy for non-smokers to enhance cognitive performance.  
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Letter of Information 
Study Title: The Acute Effects of Nicotine and Exercise on Human Cognition and 
Working Memory  
 Principal Study Investigator:  
Harry Prapavessis, Ph.D. (School of Kinesiology, The University of Western Ontario)  
Co-Investigators:  
Steven Guirguis, M.A. (School of Kinesiology, The University of Western Ontario)  
Matthew Mancuso B.Sc. (School of Kinesiology, The University of Western Ontario)  
Wuyou Sui, M.A. (School of Kinesiology, The University of Western Ontario)  
You are being invited to participate in a research study looking at the effect of an 
acute bout of moderate intensity exercise and nicotine on cognitive performance. 
Cognitive performance describes people’s performance in tasks that require either 
memory or attention. This is a countered balanced study (a type of research study in 
which each participant takes part in both groups and serves as their own control), which 
includes eligible volunteers who choose to take part. Please take your time to make a 
decision. The purpose of this letter is to provide you with the information you require to 
make an informed decision on participating in this research. This letter contains 
information to help you decide whether or not to participate in this research study. It is 
important for you to understand why the study is being conducted and what it will 
involve. Please take the time to read this carefully and feel free to ask questions if 
anything is unclear or there are words you do not understand. We are asking you to take 
part because you an adult between 18 and 65 years of age who does not smoke or have a 
history of smoking or mental illness. A total of 20 participants will be recruited for this 
study.  
Invitation to Participate in Research and Eligibility Criteria  
You are being invited to take part in this research study because you:  
 are between the ages of 18 and 45  
 Right-handed  
 do not smoke or have a history of smoking  
 do not have a mental illness  
 are not pregnant  
 do not have a medical condition that prevents you from exercising  
 are able to read and write in English  
 have a telephone or an email account that we can reach you  
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What is the purpose of this study?  
It has been shown in past research that both exercising and nicotine can help improve 
cognitive function - intellectual processes by which one becomes aware of, perceives, 
or comprehends ideas.  
In our study, we will be using an N-back computer task to measure working memory. 
The N- back task is a 5 minute task that displays a letter on a computer screen for an 
interval of 500ms, followed by a 1000ms blank screen interstimulus. You will have to 
click the left button of a computer mouse when a flashed letter on the screen is repeated 
with exactly one letter in between. For example, if the screen flashed X, then flashed 
another letter, then flashed X again, you would click the left mouse button (X here was 
the target letter).  
The N-back has been used to measure aspects of cognitive functions. The main purpose 
of this study is to examine whether the improvements caused by acute aerobic exercise is 
comparable to those of nicotine.  
WHAT ARE ASKED TO DO IN THIS STUDY?  
If you choose to participate in this study, you will be asked to attend three laboratory 
sessions at the Exercise and Health Psychology Laboratory (EHPL) located at the Arthur 
& Sonia Labatt Health Sciences Building (HSB 408) in the University of Western 
Ontario. At the first meeting you will be asked to complete the Physical Activity 
Readiness Questionnaire (PAR-Q). Each laboratory meeting will take approximately 30 
minutes and appointments will be arranged at your convenience and each appointment 
approximately a week apart. Following an outline for each laboratory session you will 
find detailed descriptions of each itemized task (1-4) that you will be asked to complete.  
During your first session at the laboratory you will be asked to complete:  
 -  Surveys (item – 1):  
o Demographic questionnaire (item – a)  
o Smoking history questionnaire (item – b)  
o Exercise behaviour in the last 7-days questionnaire (item – c)  
 -  A cognitive computer task – N-back (item – 2)  
During your second session at the laboratory you will be asked to complete:  
- Surveys (item – 1) 
Pre-exercise or pre-nicotine (item – d)  
- A treatment condition (item – 3), either: 
i) Moderate Intensity Aerobic Exercise or  
ii) Nicorette gum  
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During your third session at the laboratory you will be asked to complete:  
- Surveys (item – 1): 
Pre-exercise or pre-nicotine (item – d)  
- A treatment condition (item – 3), either: 
i) Moderate Intensity Aerobic Exercise or ii) Nicorette gum  
You are asked to abstain from alcohol for at least 18 hours prior to your laboratory 
meetings and restricted to 1⁄2 cup of coffee (item – 4).  
The task descriptions are as follows:  
1) Provide demographic and smoking and exercise information Time involvement = 
20 minutes 
The surveys will include:  
1. Demographic questionnaire (which asks you about information such as your age, 
education, marital status, income)  
2. Smoking history questionnaire (“What is the approximate date and time of the last 
cigarette you have smoked?”)  
3. Exercise behaviour in the last 7-days questionnaire (“In the last 7 days, how many 
times have you completed mild intensity exercise for 15 minutes or more?”)  
4. Pre-exercise/nicotine questionnaire will be filled out before completing either task  
2) Participate in a cognitive computer task Time involvement = 15 minutes  
3) Take part in treatment condition: i) Moderate Intensity Exercise or ii) Nicorette 
gum Time involvement = 20 minutes  
i) Moderate Intensity Exercise (You will complete a single, 20-minute bout of moderate 
intensity exercise Exercise consisted of a 2-minute warm-up, followed by 15 min of 
walking at a rate, which will allow you to reach 2/3 of your max heart rate, and then a 3-
minute cool down on a treadmill).  
a. Vital signs (heart rate and blood pressure) will be recorded just prior to, during, and 
immediately after exercise.  
ii) Nicorette gum (will chew 2 pieces of polacrilex (Nicorette®) gum once every 3 
seconds for 20 minutes) 
a. Vital signs (heart rate and blood pressure) will be recorded just prior to, and  
immediately after nicotine administration, and at the end of 20 minutes.  
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Note that you will perform both procedures (exercise, and Nicorette gum) by being 
randomized to one procedure first and then required to perform the other procedure 1-
week later  
4) Abstain from drinking alcohol/coffee for at least 18 hours  
We ask that prior to your laboratory visit you abstain from drinking alcohol and restrict to 
1⁄2 a cup of coffee for at least 18 hours.  
What are the risks associated with my involvement in this study?  
While in the study, you may experience side effects. Known side effects are listed below, 
but other effects, however unlikely, may occur that we cannot predict.  
Exercise: There are some inherent risks of injury associated with exercise participation, 
particularly among people who are not used to exercising. You may, for example, feel 
mild muscle “tightness” or soreness that lasts for a couple of days. The possible benefits 
associated with exercise may outweigh the potential minor discomfort of beginning a 
supervised, laboratory-based exercise program. To minimize the physical risks of 
exercise, proper warm- up/cool-down and stretching protocols will be performed by a 
trained exercise counsellor. Additionally, the exercise program delivered will be tailored 
to your individual fitness level, and modified according to your comfort level. 
Furthermore, you will only be allowed to participate in this exercise program if you 
complete the PAR-Q (Physical Activity Readiness Questionnaire) forms to ensure that it 
is safe for you to begin an exercise program. The exercise facilitator will be both CPR 
and First Aid trained, and experienced in working with previously inactive populations. If 
any physical or mental risks arise during treatment The Student Emergency Response 
Team (SERT) will be available to provide immediate assistance. SERT will assist the 
exercise supervisor until the 911 emergency services arrive. Should you have a minor 
injury while exercising you will receive medical treatment onsite as necessary. A first aid 
kit and ice packs will be available for minor injuries.  
NICORETTE® gum: The primary side effects of lozenge use include: sore throat, 
heartburn, nausea/indigestion, and hiccups. People who experience any of the following 
symptoms should contact their doctor immediately: irregular heartbeat or heart 
palpitations, severe throat irritation, or mouth problems. Improper use of nicotine gum 
may put people in danger of developing a nicotine overdose. Overdose symptoms require 
immediate medical attention and include dizziness, weakness, diarrhoea, nausea, 
vomiting and a rapid heart rate. Prolonged use of nicotine gum may elevate a person's 
risk of experiencing withdrawal symptoms upon ending treatment. Symptoms of 
withdrawal, such as nervousness, headache, irritability or tobacco cravings, can be 
uncomfortable. People should consult a physician to determine the best way to limit the 
risk or severity of withdrawal symptoms.  
Do I have to take part?  
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Participation in this study is voluntary. You may refuse to participate, refuse to answer 
any questions or withdraw from the study at any time with no effect on your future care. 
If you decide to take part you will be given this Letter of Information to keep and be 
asked to sign the consent form. If you withdraw from the study, you maintain the right to 
request that any data collected from you not be used in the study. If you make such a 
request, all of the data collected from you will be destroyed. Please contact the study co-
investigators, Steven Guirguis, Matthew Mancuso, or Wuyou Sui if you wish to withdraw 
from the study.  
Participation in other studies  
If you are participating in another study at this time, please inform the study researchers 
right away to determine if it is appropriate for you to participate in this study.  
New findings  
If, during the course of this study, new information becomes available that may relate to 
your willingness to continue to participate, this information will be provided to you by 
the investigator.  
Are there any costs associated with participation?  
You will receive a $10 gift card for participating in this study and will be provided with 
free parking for your visits to the laboratory if needed.  
This study is covered by an insurance policy and if during the course of the study any 
injury should occur all medical expenses necessary to treat such injury will be paid 
provided: a) you comply at all times with the study researcher’s instructions b) you 
promptly report any such injury to the study researchers conducting the study, and c) the 
expenses are not otherwise covered by your provincial health care. Financial 
compensation for such things as lost wages, disability or discomfort due to this type of 
injury is not routinely available. You do not waive any legal rights by signing the consent 
form.  
Will information obtained in the study be confidential?  
All the information you provide to the researcher will be kept in the strictest confidence. 
You will be assigned an identification number and all data collected from you will be 
recorded and stored under this number only. Study researchers will not have any way of 
connecting your data to you. All data will be stored in coded form on computers 
accessible only to research staff in a secure office. You will not be identified in any 
documents relating to the research. No information obtained during the study will be 
discussed with anyone outside of the research team. If the results of the study are 
published, your name will not be used.  
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Representatives of the University of Western Ontario Health Sciences Research Ethics 
Board may contact you or require access to your study-related records to monitor the 
conduct of the research. If we find information we are required by law to disclose, we 
cannot guarantee confidentiality. We will strive to ensure the confidentiality of your 
research-related records. Absolute confidentiality cannot be guaranteed, as we may have 
to disclose certain information under certain laws.  
Questions?  
If you have any questions about your rights as a research participant or the conduct of the 
study you may contact the Office of Research Ethics (Phone: 519-661-3036; Email: 
ethics@uwo.ca). If you have any questions about the study, please contact the study co-
investigators, Steven Guirguis, Matthew Mancuso, or Wuyou Sui  
This letter is for you to keep. You will be given a copy of this letter of information and 
consent form once it has been signed. If you have any concerns, please feel free to 
contact one of the researchers below. You may request the general findings of this 
research study from the researchers after the study is complete.  
Dr. Harry Prapavessis Professor 
School of Kinesiology, UWO  
Wuyou Sui 
M.A. Student 
School of Kinesiology, UWO  
Steven Guirguis 
M.A. Student 
School of Kinesiology, UWO  
Matthew Mancuso 
B.Sc. Student 
School of Kinesiology, UWO  
Informed Consent  
Study Title: The Acute Effects of Nicotine and Exercise on Human Cognition and 
Working Memory  
 
I have read the Letter of Information, had the nature of the study explained to me and I 
agree to participate. All questions have been answered to my satisfaction. I will be given 
a copy of the Letter of Information and consent form once it has been signed.  
Consenting Signature:  
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Participant: ________________________________________________________ 
Please Print Name  
Participant: ________________________________________________________ 
Please Sign Name  
Date: ___________________ 
Please send me the overall conclusions from this trial: Yes □ No □  
Researcher Signature: 
Person obtaining informed consent:   
Date: ____________________  
_______________________________________  
Please Print Name  
_______________________________________  
Please Sign Name  
 
 
 
 
 
 
 
 
 
 
   
 
 
64
Appendix B 
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  ID:__________ 
 
Sociodemographic Questionnaire 
 
YOUR CONTACT INFORMATION: 
 
First Name:_______________________                 Last Name:___________________________  
 
Home Phone: ________- _________-_________ 
 
Email Address: __________________________________________@_____________________  
 
Date of Birth: ________/___________               
                             MM           YYYY 
Study ID: ___________________________ 
 
 
EMERGENCY CONTACT INFORMATION: 
 
First Name:_______________________                 Last Name:___________________________  
 
Day Phone: ________- _________-_________ 
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  ID:________ 
 
 
 
Physical Activity Readiness Questionnaire (PARQ) 
 
1. Has your doctor ever said that you have a heart condition and that you should only do physical 
activity recommended by a doctor? 
a. [   ] Yes 
b. [   ] No 
 
2. Do you feel pain in your chest when you do physical activity? 
a. [   ] Yes 
b. [   ] No 
 
3. In the past month, have you had chest pain when you were not doing physical activity? 
a. [   ] Yes 
b. [   ] No 
 
4. Do you lose your balance because of dizziness or do you ever lose consciousness? 
a. [   ] Yes 
b. [   ] No 
 
5. Do you have a bone or joint problem that could be made worse by a change in your physical 
activity? 
a. [   ] Yes 
b. [   ] No 
 
6. Is your doctor currently prescribing drugs (for example, water pills) for your blood pressure or heart? 
a. [   ] Yes 
b. [   ] No 
 
7. Do you know of any other reason why you should not do physical activity? 
a. [   ] Yes 
b. [   ] No 
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  ID:________ 
 
 
 
Section A – Smoking History & Current Practices 
 
12. Have you ever smoked before?  Yes/No 
 
13. If yes, what is the approximate date and time of the last cigarette you have smoked? 
  
   Date:  ______________ Time: ________________ 
 
 
 
Section B – Exercise Behaviour: Godin Leisure-Time Exercise Questionnaire 
 
1. During the last 7 days, how many times did you do the following kinds of exercise for more than 15 
minutes during your free time (write on each line the appropriate number)? 
 
         Times Per Week 
a) STRENUOUS EXERCISE (heart beats rapidly) 
           
 (e.g., running, jogging, hockey, football, soccer,  
squash, basketball, cross country skiing, judo,  
roller skating, vigorous swimming,  
vigorous long distance bicycling).                   _____ times  
 
b) MODERATE EXERCISE (not exhausting) 
          
  (e.g., fast walking, baseball, tennis, easy bicycling,  
volleyball, badminton, easy swimming, alpine skiing,  
  popular and folk dancing).         _____ times  
 
c) MILD EXERCISE (minimal effort)          
            
(e.g., yoga, archery, fishing from river bank, bowling,  
horseshoes, golf, snow-mobiling, easy walking).     _____ times  
 
2. During the last 7-Day period (week), in your leisure time, how often did you engage in any regular 
activity long enough that your heart would beat rapidly (work up a sweat)?  
 
  
 1.  Often _______  2. Sometimes _______  3. Rarely/Never _______ 
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ID:________  
Nicotine 
Date:  
 
Have you abstained from alcohol in the past 24 hours? Yes No  
Have you limited your consumption to 1⁄2 cup of caffeine today? Yes   No   N/A  
Are you physically well today?   Yes   No  
 
Initial HR    
HR after gum  
HR after N-back  
Initial BP   
BP after gum  
BP after N-back  
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ID:________  
Exercise 
Date:  
 
Have you abstained from alcohol in the past 24 hours? Yes No  
Have you limited your consumption to 1⁄2 cup of caffeine today? Yes   No   N/A  
Are you physically well enough to be able to perform 20 minutes of moderate intensity 
exercise today?   Yes   No  
 
Initial HR    
HR at 10 minutes of exercise  
HR after exercise  
HR after N-back  
Initial BP   
BP at 10 minutes of exercise  
BP after N-back  
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 Western University             London, ON 
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control 
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anthropometric testing in overweight children with operated heart defects. 
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 Conduct fitness testing, deliver physical activity intervention, monitor and track 
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participants at 6m, 9m, and 12m. 
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ADDITIONAL QUALIFICATIONS 
 Trained to operate a Metabolic Cart, Interpret data, and create exercise prescriptions. Able to 
conduct Spirometry and Peak VO2 assessments. 
 Trained to operate Dual-Emission X-ray Absorptiometry and interpret accompanying data. Able to 
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